Skip to main content

People in the News: Anastasia Khvorova

Premium

RNAi researcher Anastasia Khvorova has joined the RNA Therapeutics Institute at the University of Massachusetts Medical School as a professor of molecular medicine.

She most recently served as CSO of RNAi drug developer RXi Pharmaceuticals, and before that was CSO of reagent firm Dharmacon, which was acquired by Thermo Fisher Scientific.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.